Articles

1-20 of 2165 < first | prev | | last >
  • The Digital Game-Changer

    For pharma operations, the question isn’t “When to go digital?” It’s “How fast can we get there?”

    Dr. Marcus Ehrhardt, Partner, PWC’S STRATEGY&
    12/09/2016
  • The Rise of Biosimilars

    North America and Europe will dominate the global biosimilars market as demand rises for these products

    Nigel Walker, Managing Director, That’s Nice / Nice Insight
    12/09/2016
  • Validation & Qualification in Pharma Facilities

    Validation, calibration and qualification are extremely critical in pharmaceutical processes. Understanding them is necessary in order to meet cGMP guidelines.

    Edward Simpson, Calibration and Technical Engineer, RS Calibration
    12/07/2016
  • Pros and Cons of Biosimilars

    There are a number of points of view and opinions on how good or necessary biosimilars actually are

    Emil W. Ciurczak, Contributing Editor
    12/07/2016
  • The Changing Biopharma Risk Equation

    Multinational survey of pharma execs offers insight on pharmaceutical companies’ growth strategies and risk management in the challenging biologics landscape

    Andrew Bulpin, vice president, Process Solutions, Merck KGaA
    11/12/2016
  • GMP in Cleanroom Maintenance: Myths and Facts

    Every cleanroom requires a carefully controlled environment maintained with Good Manufacturing Practices to prevent contamination

    Omar Lopez, MBA, Pristine Environments Inc.
    11/12/2016
  • 4 Steps for Managing Biopharmaceutical Projects

    In order for biopharma companies to move quickly and adaptively enough, an outstanding project management process is critical

    Tracy TreDenick, Head of Regulatory and Quality, and Senior Consultant, and Julie Spyrison Associate Director, Regulatory Operations at BioTechLogic, Inc.
    11/11/2016
  • No-Compromise APIs

    Hyderabad-based API provider Neuland Labs sheds the stigma of Indian manufacturers by building stringent quality control into every process

    Karen Langhauser, Chief Content Director
    11/08/2016
  • Financial Justification in Pharma

    Selection of any pharma manufacturing process, including supply chain and quality assurance practices, requires financial justification

    Girish Malhotra, PE, President, EPCOT International
    11/04/2016
  • Three Big Risks in 3D Printing Pharmaceuticals

    Are the risks of leveraging this new technology outweighing the benefits for drug makers?

    Timothy Gosnear, Senior Vice President in Major Accounts, and Daniel Brettler, Life Science and Technology Practice Leader for Conner Strong & Buckelew
    10/31/2016
  • Why Zombies Would Be Unstoppable if They Used a QMS

    Though a zombie apocalypse is decidedly scary and unpleasant, zombies tend to lack the qualities and traits that truly cataclysmic destruction requires. A QMS could help zombies take their apocalypse to the next level.

    Marci Crane Localization Manager, MasterControl
    10/27/2016
  • Pound and Penny Wise

    With capital spending on the rise, readers prioritize innovation geared toward increasing speed and efficiency

    Karen Langhauser, Chief Content Director
    10/11/2016
1-20 of 2165 < first | prev | | last >